Henry Schein, Inc.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: US8064071025
USD
73.34
1.67 (2.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Henry Schein, Inc. stock-summary
stock-summary
Henry Schein, Inc.
Retailing
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners. The Company provides its services to dental practitioners and laboratories, and physician practices, as well as government and institutional healthcare clinics.
Company Coordinates stock-summary
Company Details
135 Duryea Rd , MELVILLE NY : 11747
stock-summary
Tel: 1 631 84355001 631 3908105
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 115 Schemes (44.15%)

Foreign Institutions

Held by 291 Foreign Institutions (23.23%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Stanley Bergman
Chairman of the Board, Chief Executive Officer
Mr. James Breslawski
President, Vice Chairman of the Board, Director
Mr. Steven Paladino
Chief Financial Officer, Executive Vice President, Director
Mr. Gerald Benjamin
Chief Administrative Officer, Executive Vice President, Director
Mr. Mark Mlotek
Chief Strategic Officer, Executive Vice President, Director
Mr. Philip Laskawy
Lead Independent Director
Mr. Barry Alperin
Independent Director
Mr. Paul Brons
Independent Director
Ms. Shira Goodman
Independent Director
Mr. Joseph Herring
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3,240 Million
(Quarterly Results - Jun 2025)
Net Profit:
94 Million
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 8,215 Million (Small Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.86

stock-summary
Return on Equity

14.90%

stock-summary
Price to Book

2.38